مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,579
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

THE COMBINATION OF MOLECULAR ASPECTS OF BREAST CANCER WITH HORMONE THERAPY

Pages

  9-15

Abstract

 Background & Objectives: BREAST CANCER is one of the most common cancers in the world that is affected by various genetics, epigenetic and many other environmental factors. ESTROGEN is one of the risk factors for this cancer. This factor lead to genetic alterations and the beginning and promotion of BREAST CANCER.Materials & Methods: In this review, we provide information using databases of NCBI, PubMed, Google Scholar, and Ovid MEDLINE, about the molecular basis of BREAST CANCER, the effect of ESTROGEN hormone, and ESTROGEN receptors on cancer incidence, the use of anti-estrogens such as TAMOXIFEN in treatment of BREAST CANCER and mechanisms of resistant to these drugs.Result: Anti-estrogens such as TAMOXIFEN play an important role in treatment of ESTROGEN-receptor positive BREAST CANCERs by preventing ESTROGEN binding to its receptors in these tumors. Finding the molecular basis of BREAST CANCER will help us to achieve effective treatment for BREAST CANCER. Conclusion: Increased ESTROGEN and ESTROGEN receptor highly influence the incidence of BREAST CANCER. TAMOXIFEN is standard adjuvant therapy for women with ER-positive [+], but there is some intrinsic or acquired resistance to endocrine treatment that require further investigations.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    MAZAHERI NAEENI, MAHTA, & RABBANI, TAYEBEH. (2017). THE COMBINATION OF MOLECULAR ASPECTS OF BREAST CANCER WITH HORMONE THERAPY. JOURNAL OF SABZEVAR UNIVERSITY OF MEDICAL SCIENCES, 24(1), 9-15. SID. https://sid.ir/paper/82315/en

    Vancouver: Copy

    MAZAHERI NAEENI MAHTA, RABBANI TAYEBEH. THE COMBINATION OF MOLECULAR ASPECTS OF BREAST CANCER WITH HORMONE THERAPY. JOURNAL OF SABZEVAR UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2017;24(1):9-15. Available from: https://sid.ir/paper/82315/en

    IEEE: Copy

    MAHTA MAZAHERI NAEENI, and TAYEBEH RABBANI, “THE COMBINATION OF MOLECULAR ASPECTS OF BREAST CANCER WITH HORMONE THERAPY,” JOURNAL OF SABZEVAR UNIVERSITY OF MEDICAL SCIENCES, vol. 24, no. 1, pp. 9–15, 2017, [Online]. Available: https://sid.ir/paper/82315/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button